Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/bb/ca/0c/bbca0ca3-db94-d653-0a25-75b0f5ed34ae/mza_10495498654997001921.jpg/600x600bb.jpg
scientifica sessions.
Tabari Baker
5 episodes
16 hours ago
Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech. Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next. If you're a CEO, CMO, commercial leader, investor, or startup founder, scientifica sessions gives you insider access to the lessons, strategies, and perspectives that don't show up in press releases or pitch decks.
Show more...
Management
Business
RSS
All content for scientifica sessions. is the property of Tabari Baker and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech. Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next. If you're a CEO, CMO, commercial leader, investor, or startup founder, scientifica sessions gives you insider access to the lessons, strategies, and perspectives that don't show up in press releases or pitch decks.
Show more...
Management
Business
https://hosting-media.rs-prod.riverside.fm/media/imports/podcasts/34bdafdf-51a2-466b-b913-a1662997b278/episodes/17f85dde-4206-4bc7-aa24-fc3bf786752a/Ep3-Drew_Schiller_Validic.jpg
From Wearables to Real-World Evidence: Drew Schiller on the Future of Life Sciences
scientifica sessions.
1 hour 7 minutes 31 seconds
2 months ago
From Wearables to Real-World Evidence: Drew Schiller on the Future of Life Sciences

Episode Description

In this episode of scientifica sessions, we dive deep into the transformative world of real-world evidence (RWE) and patient-generated health data (PGHD) with Drew Schiller, CEO of Validic. As life sciences companies increasingly recognize the value of data from wearables, remote monitoring devices, and connected health platforms, Drew shares practical insights on how even resource-constrained startups and emerging biotechs can harness this data to drive medical strategy and support value-based care initiatives.

We explore the evolving regulatory landscape, including the FDA's recent action on Whoop's Blood Pressure Insights feature, and discuss how companies can navigate the fine line between wellness tools and medical devices. Drew provides actionable guidance for life sciences leaders, MSLs, and clinical strategists looking to integrate patient-generated data into their evidence strategies without breaking the bank or crossing regulatory boundaries.

Whether you're at a lean startup or a commercial-stage company, this episode offers concrete strategies for leveraging the data-rich world we live in to improve patient outcomes and build compelling value stories.

What We Covered

Defining Real-World Evidence in Early-Stage Settings

  • Understanding RWE in the context of resource-limited companies
  • Where patient-generated health data fits in the evidence ecosystem
  • Common misconceptions about collecting and using real-world data

Practical Use Cases for Life Sciences

  • Most accessible types of patient-generated data for lean teams
  • How companies are using PGHD/RWE to inform medical strategy
  • Opportunities for hyper-personalization of therapies
  • Balancing privacy, interoperability, and evidence generation

PGHD's Role in Pharma Strategy & Value-Based Care

  • How patient-generated data enables value-based care models
  • The shift from volume to value and its impact on external data sources
  • Real-world examples of remote monitoring supporting value-based initiatives
  • Why Medical Affairs and Commercial teams should prioritize PGHD

Regulatory Considerations: Learning from the FDA's Whoop Warning

  • Implications of FDA's stance on patient-generated blood pressure data
  • Navigating wearable integration without crossing medical device boundaries
  • Ensuring compliance while harnessing continuous health data
  • Future partnerships between life sciences and digital health platforms

Strategic Advice for Data-Driven Evidence

  • Guidance for biotech CMOs and VPs of Medical Affairs
  • The future of wearable/app data in value dossiers and HEOR submissions
  • Recommended platforms and partners for startups vs. larger companies

Guest Bio

Drew Schiller is the co-founder and CEO of Validic, a leading digital health platform connecting personal health data from wearables, in-home devices, and mobile apps to healthcare companies, systems, and providers. Under his leadership, Validic has powered scalable remote patient monitoring and real-world data strategies for some of the largest healthcare organizations in the world.

A recognized voice in connected health and digital transformation, Drew serves on the board of the Consumer Technology Association's Health Division, in addition to serving on various industry boards. Drew brings a product-driven perspective to healthcare innovation, helping organizations design and implement real-world evidence strategies that center on patient-generated health data.

He is passionate about empowering companies with real-time, high-resolution insights to improve patient outcomes—especially in lean, early-stage settings where traditional data infrastructure may be limited.

Connect with Drew:

  • Website: validic.com
  • LinkedIn: Drew Schiller
  • Email: drew@validic.com

If you're leading a startup or emerging biotech and wondering how to tap into real-world patient data without massive infrastructure investment, visit validic.com. Validic helps organizations of all sizes connect wearable, app, and in-home health data into evidence strategies that actually work. Start thinking differently about how you engage with patients, evidence, and digital health.

If this conversation sparked new ideas or made you rethink how you align discovery with downstream strategy, subscribe to scientifica sessions. We bring you the leaders shaping what's next in biotech, medtech, and pharma.  Connect with us at podcast@kronosscientifica.com.


scientifica sessions is produced by kronos scientifica, exploring the intersection of innovation, evidence, and strategy in life sciences.

 

At scientifica sessions, we love our music!  Here's are the original tracks used:

1. 00:07:42 - Whirl
2. 00:15:30 - A Night in November
3. 00:21:06 - Night Walk
4. 00:26:28 - Rico Clave
5. 00:38:30 - Bubble Trouble
6. 00:47:37 - UP!
7. 00:56:22 - A Different Cat

 

Episode recorded on July 21, 2025.  All information shared is current as of the recording date.

scientifica sessions.
Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech. Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next. If you're a CEO, CMO, commercial leader, investor, or startup founder, scientifica sessions gives you insider access to the lessons, strategies, and perspectives that don't show up in press releases or pitch decks.